• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Development and Evaluation of a Novel Chimeric Genotype VII Newcastle Disease Vaccine: Overcoming Maternal Antibody Interference and Spray Administration.

作者信息

Wang Xiaoquan, Yao Yao, Yang Wenhao, Lu Xiaolong, Gao Ruyi, Liu Kaituo, Chen Yu, Gu Min, Hu Jiao, Hu Shunlin, Liu Xiufan, Liu Xiaowen

机构信息

Key Laboratory of Avian Bioproducts Development, Ministry of Agriculture and Rural Affairs, School of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.

Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou 225009, China.

出版信息

Vet Sci. 2024 Nov 1;11(11):532. doi: 10.3390/vetsci11110532.

DOI:10.3390/vetsci11110532
PMID:39591306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11599132/
Abstract

Newcastle disease virus (NDV) poses a significant threat to the poultry industry, with the emergence of genotype VII NDV leading to extensive outbreaks and economic losses. Vaccination is the primary means of controlling NDV, but the presence of maternal antibodies (MDAs) can interfere with the immunological effect of live virus vaccines. Thus, we constructed a chimeric NDV live virus vaccine, LX-OAI4S, by replacing the extracellular regions of the F and HN genes of the NDV LX strain with the corresponding regions of the A-VII vaccine strain. The chimeric vaccine LX-OAI4S demonstrated high genetic stability, good safety, and strong reproductive capacity in chicken embryos. The LX-OAI4S vaccine induced rapid antibody production in specific pathogen-free (SPF) and commercial chickens via the intranasal and intraocular (IN/IO) routes, with hemagglutination inhibition (HI) antibody titers reaching 4.71 ± 1.03 log at 7 days post-vaccination (dpv), significantly higher than those of the two classical vaccine strains La Sota and VG/GA. The LX-OAI4S vaccine group provided effective protection against the challenge of genotype VII NDV virulent strain JS2/06 and inhibited viral shedding. When administered via spray, the LX-OAI4S vaccine elicited high systemic immunity against NDV in both SPF and commercial chickens, effectively protecting against clinical disease and reducing viral shedding. The chickens were exposed to high-dose vaccine for spray vaccination, and no adverse reactions were observed after vaccination. Despite the presence of anti-NDV MDAs in chickens, the NDV-specific antibody titers were significantly greater in the vaccinated groups than in the unvaccinated group. The vaccine exhibited high immunogenicity and the potential to overcome maternal antibody interference. The LX-OAI4S vaccine is a promising candidate for an ND vaccine. Its administration via spray can effectively prevent the occurrence of ND, making it a valuable tool for the poultry industry.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/11599132/4977b3fb4f63/vetsci-11-00532-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/11599132/437907bdd394/vetsci-11-00532-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/11599132/9c37db3d98f4/vetsci-11-00532-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/11599132/72701e396204/vetsci-11-00532-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/11599132/fd34f6bbc34b/vetsci-11-00532-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/11599132/a9db4522c842/vetsci-11-00532-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/11599132/4a77885fa2bd/vetsci-11-00532-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/11599132/4977b3fb4f63/vetsci-11-00532-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/11599132/437907bdd394/vetsci-11-00532-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/11599132/9c37db3d98f4/vetsci-11-00532-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/11599132/72701e396204/vetsci-11-00532-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/11599132/fd34f6bbc34b/vetsci-11-00532-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/11599132/a9db4522c842/vetsci-11-00532-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/11599132/4a77885fa2bd/vetsci-11-00532-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/11599132/4977b3fb4f63/vetsci-11-00532-g007.jpg

相似文献

1
Development and Evaluation of a Novel Chimeric Genotype VII Newcastle Disease Vaccine: Overcoming Maternal Antibody Interference and Spray Administration.
Vet Sci. 2024 Nov 1;11(11):532. doi: 10.3390/vetsci11110532.
2
Spray vaccination with a safe and bivalent H9N2 recombinant chimeric NDV vector vaccine elicits complete protection against NDV and H9N2 AIV challenge.用安全的二价H9N2重组嵌合新城疫病毒(NDV)载体疫苗进行喷雾免疫接种,可引发针对新城疫病毒和H9N2禽流感病毒(AIV)攻击的完全保护作用。
Vet Res. 2025 Jan 31;56(1):24. doi: 10.1186/s13567-025-01448-5.
3
Evaluation of the Newcastle disease virus genotype VII-mismatched vaccines in SPF chickens: A challenge efficacy study.新城疫病毒VII型不匹配疫苗在无特定病原体鸡中的评估:一项攻毒效力研究。
Vet Anim Sci. 2024 Mar 28;24:100348. doi: 10.1016/j.vas.2024.100348. eCollection 2024 Jun.
4
Recombinant Newcastle disease virus (NDV) La Sota expressing the haemagglutinin-neuraminidase protein of genotype VII NDV shows improved protection efficacy against NDV challenge.表达VII型新城疫病毒血凝素神经氨酸酶蛋白的重组新城疫病毒La Sota株对新城疫病毒攻击显示出更高的保护效力。
Avian Pathol. 2019 Apr;48(2):91-97. doi: 10.1080/03079457.2018.1548754. Epub 2018 Dec 10.
5
Efficacy of Newcastle disease LaSota vaccine-induced hemagglutination inhibition antibodies against challenges with heterologous virulent strains of genotypes VII and IX.新城疫 LaSota 疫苗诱导的血凝抑制抗体对基因型 VII 和 IX 异源强毒株攻毒的效力。
Vet Immunol Immunopathol. 2023 May;259:110591. doi: 10.1016/j.vetimm.2023.110591. Epub 2023 Apr 5.
6
Development of a genotype-matched Newcastle disease DNA vaccine candidate adjuvanted with IL-28b for the control of targeted velogenic strains of Newcastle disease virus in Africa.开发一种与基因型匹配的新城疫 DNA 疫苗候选物,并用 IL-28b 作为佐剂,以控制非洲针对特定强毒力新城疫病毒株的疾病。
Vet Res Commun. 2024 Nov 25;49(1):33. doi: 10.1007/s11259-024-10590-y.
7
Simultaneous Expression of Chicken Granulocyte Monocyte Colony-Stimulating Factor and the Hemagglutinin-Neuraminidase Epitope of the Virulent Newcastle Disease Virus Genotype VII C22 Strain in a Functional Synthetic Recombinant Adenovirus as a Genotype-Matched Vaccine with Potential Antiviral Activity.在一种功能性合成重组腺病毒中同时表达鸡粒细胞-单核细胞集落刺激因子和强毒新城疫病毒基因型 VII C22 株的血凝素-神经氨酸酶表位,作为具有潜在抗病毒活性的基因型匹配疫苗。
Microbiol Spectr. 2023 Jun 15;11(3):e0402422. doi: 10.1128/spectrum.04024-22. Epub 2023 Apr 10.
8
Spray vaccination with a Newcastle disease virus (NDV)-vectored infectious laryngotracheitis (ILT) vaccine protects commercial chickens from ILT in the presence of maternally-derived antibodies.喷雾接种新城疫病毒(NDV)载体传染性喉气管炎(ILT)疫苗可在母源抗体存在的情况下保护商业肉鸡免受 ILT 的侵害。
Avian Pathol. 2024 Dec;53(6):533-539. doi: 10.1080/03079457.2024.2356676. Epub 2024 Jul 11.
9
Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens.商品性鸡新城疫病毒灭活疫苗对鸡新城疫病毒基因型 VII 的效力比较。
Poult Sci. 2019 May 1;98(5):2000-2007. doi: 10.3382/ps/pey559.
10
The protection conferred against virulent Newcastle disease virus (vNDV) genotype VII by commercial double recombinant HVT vaccines and NDV live-attenuated vaccine as prime/boost vaccination regimens in commercial broiler chickens carrying maternally-derived antibodies (MDAs) against NDV.带有母源抗体(MDA)的商品代肉鸡中,使用商业的双重组 HVT 疫苗和 NDV 活疫苗作为初免-加强免疫程序,对强毒新城疫病毒(vNDV)基因型 VII 的保护作用。
Avian Pathol. 2023 Aug;52(4):251-263. doi: 10.1080/03079457.2023.2211548. Epub 2023 Jun 8.

引用本文的文献

1
Genetic Diversity of Newcastle Disease Virus and Its Implications for Vaccine Development.新城疫病毒的遗传多样性及其对疫苗研发的意义。
Vet Sci. 2025 Sep 4;12(9):858. doi: 10.3390/vetsci12090858.